Results 191 to 200 of about 1,954,687 (382)
The authors have discovered that intracellular interleukin 1 receptor 2 (IL1R2) negatively regulates pyroptosis and inflammation by inhibiting glycolysis in sepsis. Soluble IL1R2 is released from macrophages undergoing pyroptosis. IL1R2 acts as a novel negative regulator of glycolysis by interacting with enolase 1 (ENO1), thereby inhibiting gasdermin D
Chuyi Tan+13 more
wiley +1 more source
Clinical discovery and the proposed underlying mechanism by how P. johnsonii ameliorated metabolic disorders. Abstract The gut bacterium Parabacteroides spp. is increasingly recognized for its therapeutic potential in treating metabolic disorders. However, the role of Parabacteroides johnsonii in metabolic disorders is never reported.
Yimeng Chen+9 more
wiley +1 more source
Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer [PDF]
H. M. Quah+3 more
openalex +1 more source
Minimizing Sexual Dysfunction in BPH Surgery
J. Leong, A. Patel, R. Ramasamy
semanticscholar +1 more source
Cisplatin causes reactive oxygen species accumulation, leading to apoptosis and inflammation in cochlear hair cells. Small extracellular vesicles primarily derived from the damaged hair cells likely contribute to cisplatin‐induced ototoxicity, carrying a variety of microRNAs and proteins.
Jingru Ai+14 more
wiley +1 more source
Sexual dysfunction and quality of life in males with genital warts. [PDF]
Elhamady MM+4 more
europepmc +1 more source
Sexual dysfunction in patients taking conventional antipsychotic medication [PDF]
Shubuladè Smith+2 more
openalex +1 more source
A novel RBC indicator, ESI, is better than the traditional RBC indicators and is associated with CHF prevalence and in‐hospital death. RBC membrane lipidomics, Cer 18:0;O2/16:0, and LPE 18:0, are associated with plasma volume overload and MACE in CHF patients, but these plasma lipids could not.
Lin Zhang+12 more
wiley +1 more source
Sexual dysfunction and perceptions of rheumatologist engagement on this issue in patients with systemic sclerosis. [PDF]
Morales LM+4 more
europepmc +1 more source